首页> 外国专利> VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE

VECTOR(S) CONTAINING AN INDUCIBLE GENE ENCODING A CDK4/CDK6 INHIBITOR USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS OR DISEASES ASSOCIATED WITH AN UNSCHEDULED ACTIVATION OF THE CELL CYCLE

机译:包含可编码CDK4 / CDK6抑制剂的可疑基因的载体,可用于治疗神经退行性疾病或与细胞周期异常激活有关的疾病

摘要

Described are vectors containing (a) a gene encoding (i) a CDK4/CDK6 inhibitor, preferably p16INK4a, or (ii) an RNA interfering with CDK4 and/or CDK6 expression and/or activity, under the control of an inducible promoter and (b) a gene encoding a transactivator protein for said promoter useful for treating neurodegenerative disorders. These vectors can be transferred into cells where they will exert a protective function to (i) prevent cell death or to (ii) slow down progression of cell death. These vectors can be used in therapeutic applications to prevent neurodegenerative disorders or to slow down their progression with therapeutic efficacy.
机译:所描述的载体包含:(a)在以下条件下编码(i)CDK4 / CDK6抑制剂,优选p16 INK4a 的基因,或(ii)干扰CDK4和/或CDK6表达和/或活性的RNA。诱导型启动子的控制,以及(b)所述启动子的编码反式激活蛋白的基因,可用于治疗神经退行性疾病。这些载体可以转移到细胞中,在细胞中它们将发挥保护作用以(i)预防细胞死亡或(ii)减慢细胞死亡进程。这些载体可用于治疗应用中,以预防神经退行性疾病或减慢其发展的疗效。

著录项

  • 公开/公告号US2012004277A1

    专利类型

  • 公开/公告日2012-01-05

    原文格式PDF

  • 申请/专利权人 THOMAS ARENDT;UWE UEBERHAM;

    申请/专利号US201013146592

  • 发明设计人 THOMAS ARENDT;UWE UEBERHAM;

    申请日2010-02-04

  • 分类号A61K31/7088;A61P25;A61P25/28;C12N15/63;C12N15/85;

  • 国家 US

  • 入库时间 2022-08-21 17:28:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号